-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Evofem Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
- Evofem Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $203K, a 21.3% decline year-over-year.
- Evofem Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $905K, a 19.7% decline year-over-year.
- Evofem Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.19M, a 64.1% decline from 2022.
- Evofem Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.31M, a 62.8% decline from 2021.
- Evofem Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.9M, a 29.9% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)